FIELD: biotechnology, in particular cell therapy.
SUBSTANCE: invention relates to production of mesenchymal stem cells from human marrow. Uniform population of mesenchymal stem cells characterized with cell markers CD 44+, CD 45+, CD 34-, CD 90+, CD 105+, CD 106+ is isolated. Uniform cells are obtained on media interface during centrifugation of heparinized marrow and cells are subcultured in medium with addition cow foetus serum to produce cell biomass.
EFFECT: accelerated and inexpensive method for production of mesenchymal stem cells.
7 cl, 2 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING AND MAINTAINING MESENCHYMAL STEM CELLS FROM MAMMALIAN BONE MATERIAL | 2023 |
|
RU2821926C1 |
METHOD FOR PRODUCTION OF MESENCHYMAL STEM CELLS AND BIOTRANSPLANT USING THE SAME | 2006 |
|
RU2303631C1 |
METHOD FOR ISOLATION OF MESENCHYMAL STEM CELLS | 2004 |
|
RU2252252C1 |
METHOD FOR CULTURING HUMAN MESENCHYMAL STEM CELLS EX VIVO | 2006 |
|
RU2323252C1 |
METHOD OF MESENCHYMAL STEM CELL ISOLATION FROM BONE MARROW BEFORE CULTIVATION | 2010 |
|
RU2425873C1 |
METHOD FOR OBTAINING OF BIOSAFE CULTURE OF MESENCHIMAL STEM CELLS FROM HUMAN CHORIONIC VILLAE | 2016 |
|
RU2645255C1 |
METHOD OF ACCELERATED ACQUIRING OF MESENCHYMAL STEM CELLS (MSC) CULTURE OF MAMMALS, EXCEPT HUMAN, WITH LOW HETEROGENEITY AND HIGH VIABILITY | 2007 |
|
RU2331670C1 |
METHOD FOR OBTAINING BIOSAFE CULTURE OF MESENCHYMAL STEM CELLS FROM GELATIN OF WHARTON OF HUMAN UMBILICAL CORD | 2016 |
|
RU2674344C2 |
METHOD OF CULTIVATING MESENCHYMAL STEM CELLS, ISOLATED FROM BONE MARROW | 2011 |
|
RU2517112C2 |
MESENCHYMAL STROMAL CELLS AND METHODS FOR OBTAINING MESENCHYMAL STROMAL CELLS FROM THE UMBILICAL CORD | 2018 |
|
RU2793467C2 |
Authors
Dates
2007-07-27—Published
2006-04-04—Filed